These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18068530)

  • 1. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
    Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
    Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
    Yasui K; Arii S; Zhao C; Imoto I; Ueda M; Nagai H; Emi M; Inazawa J
    Hepatology; 2002 Jun; 35(6):1476-84. PubMed ID: 12029633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].
    Li JT; Liu W; Kuang ZH; Chen HK; Li DJ; Feng QS; Liu QC; Hu B
    Ai Zheng; 2003 Jul; 22(7):695-9. PubMed ID: 12866958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
    Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
    Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
    Tsuji K; Yasui K; Gen Y; Endo M; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Cancer Genet Cytogenet; 2010 Apr; 198(2):118-25. PubMed ID: 20362226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
    Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
    Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma.
    Huang TJ; Huang BJ; Liang QW; Huang CW; Fang Y
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):62-8. PubMed ID: 14969840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of the regions of copy number amplification associated with hepatocellular carcinoma].
    Zhang SG; Gao YT; Song WQ; Du Z; Yang B; Wang YJ; Zhu ZY
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):566-70. PubMed ID: 20021941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.
    Midorikawa Y; Yamamoto S; Ishikawa S; Kamimura N; Igarashi H; Sugimura H; Makuuchi M; Aburatani H
    Oncogene; 2006 Sep; 25(40):5581-90. PubMed ID: 16785998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry.
    Zen K; Yasui K; Nakajima T; Zen Y; Zen K; Gen Y; Mitsuyoshi H; Minami M; Mitsufuji S; Tanaka S; Itoh Y; Nakanuma Y; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
    Genes Chromosomes Cancer; 2009 Feb; 48(2):109-20. PubMed ID: 18973138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
    Ma NF; Hu L; Fung JM; Xie D; Zheng BJ; Chen L; Tang DJ; Fu L; Wu Z; Chen M; Fang Y; Guan XY
    Hepatology; 2008 Feb; 47(2):503-10. PubMed ID: 18023026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13.
    Karakoula K; Suarez-Merino B; Ward S; Phipps KP; Harkness W; Hayward R; Thompson D; Jacques TS; Harding B; Beck J; Thomas DG; Warr TJ
    Genes Chromosomes Cancer; 2008 Nov; 47(11):1005-22. PubMed ID: 18663750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
    Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
    J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
    Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
    Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative detection of HER-2 oncogene amplification in primary hepatocellular carcinoma using dual FISH technique and its clinical significance].
    Huang BJ; Huang TJ; Liang QW; Huang CW; Fang Y
    Yi Chuan Xue Bao; 2001; 28(9):793-800. PubMed ID: 11582736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.
    Kuuselo R; Savinainen K; Azorsa DO; Basu GD; Karhu R; Tuzmen S; Mousses S; Kallioniemi A
    Cancer Res; 2007 Mar; 67(5):1943-9. PubMed ID: 17332321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.
    Wong N; Chan A; Lee SW; Lam E; To KF; Lai PB; Li XN; Liew CT; Johnson PJ
    J Hepatol; 2003 Mar; 38(3):298-306. PubMed ID: 12586295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.